Researchers have developed a novel preclinical mouse model of spinocerebellar ataxia 13 (SCA13) that demonstrates a strong association between neuroinflammation and the progressive loss of Purkinje cells in the cerebellum. Published in Acta Neuropathologica Communications, the study provides a new tool for investigating the mechanisms underlying this heterogeneous neurodegenerative ataxia, which currently lacks effective treatments. The team engineered a specific mutation into mice to mimic the human disease allele, allowing for detailed phenotypic and pathological analyses that highlight the potential role of the immune system in disease progression.
SCA13 is characterized by several allelic variations that result in differing phenotypes, all of which are neurodegenerative in nature. Previous work by the research group identified mutations in the human KCNC3 gene as causative for the condition. Specifically, the R423H allelic isoform was found to drive early-onset neurodegeneration. Despite this genetic understanding, the precise nature of the inflammatory response in SCA13 and its direct link to neurodegeneration remained elusive prior to this study. The new research aims to address this gap by creating a model that accurately reflects the molecular defect in the human disease.
To create the model, the researchers used CRISPR/Cas9 technology to engineer a single Kcnc3 R424H mutation into mice. The resulting transgenic mice provided a platform for thorough phenotypic analyses. The team assessed motor function, including gait, tremor, coordination, and balance, as well as brain segmental and cerebellar volume at multiple timepoints.
At 3 and 6 months of age, the R424H mice displayed profound neurological motor dysfunction. Specific observations included high-frequency tremor, aberrant gait patterns, and a decreased latency to fall during balance tests. These functional deficits were accompanied by pathological changes, with examination confirming progressive Purkinje cell degeneration and cerebellar atrophy. The combination of motor, electrophysiological, and histological data established the model as a valid representation of the neurodegenerative aspects of SCA13.
A critical finding of the study was the pronounced activation of microglia and astrocytes within the cerebella of the R424H mice. The research team investigated both neurodegenerative Purkinje cell loss and these inflammatory responses within the cerebellum, as well as systemic inflammatory markers through plasma cytokine levels. The observation of significant neuroinflammation suggests that the immune response is not merely a byproduct of cell death but may be an active component of the disease process.
Statistical analyses further supported the link between inflammation and neurodegeneration. Pearson correlation analyses highlighted a strong inverse correlation between the number of surviving Purkinje cells and markers of inflammatory activation. This means that as inflammatory markers increased, the number of healthy Purkinje cells decreased. While correlation does not prove causation, the strength of this association in the model provides compelling evidence that aberrant activation of inflammatory immune cells is associated with Purkinje cell demise in the cerebellum. The study proposes that this neuroinflammation may play a significant and potentially aggressive role in driving the progression of neurodegeneration in SCA13.
The study has several important implications for the field of neurodegenerative disease research. The model mimics the SCA13 R423H allele, allowing researchers to study the specific pathophysiology of this variant.
Limitations of the study include the fact that it was conducted in a preclinical mouse model, which may not fully recapitulate the complexity of the human disease. The study focused on a specific allelic variant, and it is unclear if the same inflammatory mechanisms apply to other SCA13 variants. Additionally, while the study identified a strong correlation between inflammation and cell loss, it did not definitively prove that inflammation drives the neurodegeneration. Future studies will be needed to dissect the causal relationship between these two processes. Nevertheless, this study provides a valuable foundation for understanding the role of neuroinflammation in SCA13 and other neurodegenerative disorders.
Subject of Research: Preclinical mouse model of spinocerebellar ataxia 13 linking neuroinflammation to Purkinje cell degeneration
Article Title: Neurodegeneration and inflammation in a novel spinocerebellar ataxia 13 preclinical model
Article References: Yin, J., Wu, M., White, J., Khare, S., Nick, J. A., Zuberi, A. R., Gao, M., Lutz, C. M., Allen, K. D., Stokes, A., Nick, H. S., & Waters, M. F. (2026). Neurodegeneration and inflammation in a novel spinocerebellar ataxia 13 preclinical model. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-026-02436-2
Image Credits: AI Generated
DOI: 10.1186/s40478-026-02436-2
Keywords: SCA13, Neurodegeneration, Neuroinflammation, Purkinje cells, KCNC3, Mouse model, Cerebellum, CRISPR/Cas9, Microglia, Astrocytes, inflammation, novel
News Source: Diana Fleming. (November 10, 2026). Mouse Model Links Inflammation to SCA13 Neurodegeneration. Scienmag.



